Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana

Introduction: Hepatitis B Virus (HBV) infection is an important occupational hazard to Health Care Workers (HCWs) all over the world. International health organizations have strongly recommended the use of the HBV vaccine, especially among individuals at risk of HBV infection. A laboratory test aime...

Full description

Bibliographic Details
Main Authors: Senoo-Dogbey Vivian Efua, Deborah Armah, Wuaku Delali Adwoa
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Vaccine: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136223000359
_version_ 1827875655947124736
author Senoo-Dogbey Vivian Efua
Deborah Armah
Wuaku Delali Adwoa
author_facet Senoo-Dogbey Vivian Efua
Deborah Armah
Wuaku Delali Adwoa
author_sort Senoo-Dogbey Vivian Efua
collection DOAJ
description Introduction: Hepatitis B Virus (HBV) infection is an important occupational hazard to Health Care Workers (HCWs) all over the world. International health organizations have strongly recommended the use of the HBV vaccine, especially among individuals at risk of HBV infection. A laboratory test aimed at measuring Anti-HBs concentration (titer) 1–2 months following a 3-dose vaccination schedule is the most reliable approach for diagnosing seroprotection against HBV. This study sought to assess post-vaccination serological testing, seroprotection against HBV, and associated factors among vaccinated HCWs in Ghana. Methods: A hospital-based analytical cross-sectional study involving 207 HCWs. Pretested questionnaires were used to collect data. 5mls of venous blood were collected from consenting HCWs under strict aseptic conditions and quantitatively analyzed for Anti-HBs using ELISA procedures. SPSS Version 23 was used to analyze data with the level of significance set at 0.05. Results: Median age; 33, IQR of 29–39. The post-vaccination serological testing rate was 21.3 %. HCWs with high-risk perception and working at the regional hospital had lower odds of adherence to post-vaccination serological testing (aOR = 0.2; 95 % CI = 0.1–0.7) and (aOR = 0.1; 95 % CI = 0.1–0.6) p < 0.05. The seroprotection rate was 91.3 % (95 % CI = 87 %-95 %). Minority, 18 (8.7 %) of the 207 vaccinated HCWs had antibody titers below 10mIU/mL and were not seroprotected against HBV. Geometric Mean Titers (GMTs) were higher in those who received three doses, took a booster, and were less than 25 kg/m2. Conclusion: The post-vaccination serological testing practice was sub-optimal. The seroprotection rate was higher with higher GMTs in those who adhered to the 3-dose vaccination regimen, took a booster dose, and had BMI < 25 kg/m2. It may be inferred that those with Anti-HBs below 10 IU/ml had their antibodies diminishing or waning off with time or they are true vaccine non-responders. This observation calls for strict adherence to post-vaccination serological testing, especially for HCWs who are at high risk of percutaneous and mucocutaneous exposures that could result in HBV infection.
first_indexed 2024-03-12T17:11:02Z
format Article
id doaj.art-2c13862e9f494bb4aaf142e1afcc27e3
institution Directory Open Access Journal
issn 2590-1362
language English
last_indexed 2024-03-12T17:11:02Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series Vaccine: X
spelling doaj.art-2c13862e9f494bb4aaf142e1afcc27e32023-08-06T04:38:07ZengElsevierVaccine: X2590-13622023-08-0114100294Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, GhanaSenoo-Dogbey Vivian Efua0Deborah Armah1Wuaku Delali Adwoa2Department of Public Health, School of Nursing and Midwifery, University of Ghana, P. O. Box LG 25, Legon, Accra, Ghana; Corresponding author.Department of Maternal and Child Health, School of Nursing and Midwifery, University of Ghana, P. O. Box LG 25, Legon, Accra, GhanaDepartment of Nursing Research, Nursing, and Midwifery Training School, P. O Box KB 83 Korle-Bu, Accra, GhanaIntroduction: Hepatitis B Virus (HBV) infection is an important occupational hazard to Health Care Workers (HCWs) all over the world. International health organizations have strongly recommended the use of the HBV vaccine, especially among individuals at risk of HBV infection. A laboratory test aimed at measuring Anti-HBs concentration (titer) 1–2 months following a 3-dose vaccination schedule is the most reliable approach for diagnosing seroprotection against HBV. This study sought to assess post-vaccination serological testing, seroprotection against HBV, and associated factors among vaccinated HCWs in Ghana. Methods: A hospital-based analytical cross-sectional study involving 207 HCWs. Pretested questionnaires were used to collect data. 5mls of venous blood were collected from consenting HCWs under strict aseptic conditions and quantitatively analyzed for Anti-HBs using ELISA procedures. SPSS Version 23 was used to analyze data with the level of significance set at 0.05. Results: Median age; 33, IQR of 29–39. The post-vaccination serological testing rate was 21.3 %. HCWs with high-risk perception and working at the regional hospital had lower odds of adherence to post-vaccination serological testing (aOR = 0.2; 95 % CI = 0.1–0.7) and (aOR = 0.1; 95 % CI = 0.1–0.6) p < 0.05. The seroprotection rate was 91.3 % (95 % CI = 87 %-95 %). Minority, 18 (8.7 %) of the 207 vaccinated HCWs had antibody titers below 10mIU/mL and were not seroprotected against HBV. Geometric Mean Titers (GMTs) were higher in those who received three doses, took a booster, and were less than 25 kg/m2. Conclusion: The post-vaccination serological testing practice was sub-optimal. The seroprotection rate was higher with higher GMTs in those who adhered to the 3-dose vaccination regimen, took a booster dose, and had BMI < 25 kg/m2. It may be inferred that those with Anti-HBs below 10 IU/ml had their antibodies diminishing or waning off with time or they are true vaccine non-responders. This observation calls for strict adherence to post-vaccination serological testing, especially for HCWs who are at high risk of percutaneous and mucocutaneous exposures that could result in HBV infection.http://www.sciencedirect.com/science/article/pii/S2590136223000359AntibodiesHealth care workersHepatitis BSeroprotectionSerological testingVaccination
spellingShingle Senoo-Dogbey Vivian Efua
Deborah Armah
Wuaku Delali Adwoa
Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana
Vaccine: X
Antibodies
Health care workers
Hepatitis B
Seroprotection
Serological testing
Vaccination
title Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana
title_full Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana
title_fullStr Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana
title_full_unstemmed Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana
title_short Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana
title_sort hepatitis b virus vaccination post serological testing and antibody levels of vaccinated health care workers in accra ghana
topic Antibodies
Health care workers
Hepatitis B
Seroprotection
Serological testing
Vaccination
url http://www.sciencedirect.com/science/article/pii/S2590136223000359
work_keys_str_mv AT senoodogbeyvivianefua hepatitisbvirusvaccinationpostserologicaltestingandantibodylevelsofvaccinatedhealthcareworkersinaccraghana
AT deboraharmah hepatitisbvirusvaccinationpostserologicaltestingandantibodylevelsofvaccinatedhealthcareworkersinaccraghana
AT wuakudelaliadwoa hepatitisbvirusvaccinationpostserologicaltestingandantibodylevelsofvaccinatedhealthcareworkersinaccraghana